A regulatory overview of entering the most significant countries’ market

Algeria

Algeria

DPM

argentina

Argentina

ANMAT

Algeria

Australia

TGA

biellorussia

Belarus

NCE e MOH

brasile

Brasil

ANVISA

canada

Canada

HC

cina

China

NMPA

colombia

Colombia

INVIMA

croazia

Croatia

HALMED

egitto

Egypt

EDA

emirati arabi

Emirati Arabi Uniti

DCD

etiopia

Ethiopia

FMHACA

europa

Europe

European Commission

francia

France

ANSM

germania

Germany

BfArM

ghana

Ghana

MDD of the FDA

india

India

CDSCO

indonesia

Indonesia

MoH DGPS & MD

iran

Iran

COME

israele

Israel

AMAR

italia

Italy

Ministero della Salute

giappone

Japan

PMDA

kazakistan

Kazakistan

NC for M, MD& MEE

lituania

Lithuania

VASPVT

malesia

Malaysia

MDA

marocco

Marocco

DMP

messico

Mexico

COFEPRIS

Pakistan

DRAP

filippine

Philippines

FDA

portogallo

Portugal

INFARMED

russia

Russia

Roszdravnadzor

Arabia saudita

Saudi Arabia

SFDA

singapore

Singapore

HSA

sudafrica

South Africa

SAHPRA

corea sud

South Corea

MFDS

spagna

Spain

AEMPS

svizzera

Switzerland

Swissmedic

taiwan

Taiwan

TFDA

thailandia

Thailand

FDA thailandese

tunisia

Tunisia

DPM

turchia

Turkey

TMMDA

ucraina

Ukraine

SAUMP

inghilterra

United Kingdom

MHRA

usa

USA

US FDA

venezuela

Venezuela

MPPS, SACS, OICEMP

vietnam

Vietnam

DME and CMH